Advertisement
Screener

AMERICAN SHARED HOSPITAL SERVICES (AMS) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

AMERICAN SHARED HOSPITAL SERVICES Cash Flow Breakdown

Cash flow breakdown shows where AMERICAN SHARED HOSPITAL SERVICES's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $3.10M came in.
  • Fiscal year ended 2025-12-31: from investing, $7.63M went out.
  • Fiscal year ended 2025-12-31: from financing, $3.03M went out.
  • Fiscal year ended 2025-12-31: change in cash, $7.56M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtCommercial paperNew shares soldNot split outChange in cash
2025-12-31$3.10M-$7.63M-$3.01M$0.00$9.00M*-$7.56M
2024-12-31$167.00K-$7.11M-$2.73M$9.86M$10.90M-$13.62M*-$2.53M
2023-12-31$5.72M-$6.27M-$2.13M$1.75M*$3.90M$0.00$1.35M
2022-12-31$7.24M-$388.00K-$2.03M*$0.00$0.00$5.00K-$630.00K*$4.19M
2021-12-31$6.27M-$1.67M-$4.33M*$13.90M$5.00K-$10.23M*$3.94M
2020-12-31$9.74M-$2.39M-$1.73M*$0.00$0.00-$3.08M*$2.55M
2019-12-31$8.05M-$990.00K-$1.98M$42.00K-$5.13M*-$13.00K
2018-12-31$8.06M-$1.53M-$2.47M$0.00-$4.78M*-$710.00K
2017-12-31$7.85M-$653.00K-$2.31M$6.00K-$5.51M*-$619.00K
2016-12-31$8.38M-$1.04M$0.00-$2.97M-$3.51M*$862.00K
2015-12-31$8.55M-$910.00K$0.00-$2.06M-$4.43M*$1.15M
2014-12-31$6.77M-$4.45M-$2.00K-$3.26M-$842.00K
2013-12-31$8.08M-$1.72M$0.00-$3.52M-$2.50M*$333.00K
2012-12-31$6.87M-$6.67M-$28.00K-$6.82M$5.62M*-$1.02M
2011-12-31$6.85M-$5.65M$0.00-$3.89M*$1.17M
2010-12-31$7.18M-$315.00K$0.00-$5.38M-$883.00K*$605.00K
2009-12-31$7.70M-$10.14M-$271.00K-$6.81M-$9.45M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtCommercial paperNew shares soldNot split outChange in cash
2026-06-30$2.24M*-$58.00K*-$640.00K*$0.00*
2026-03-31$2.15M-$41.00K-$472.00K$0.00$1.51M
2025-12-31-$704.00K*$1.98M*-$913.00K*$0.00*$0.00*-$2.00M*
2025-09-30$1.67M*-$3.70M*-$934.00K*$0.00*$2.00M*-$5.02M*
2025-06-30-$372.00K*-$1.90M*-$887.00K*$0.00*$5.00M*-$2.00M*
2025-03-31$2.50M-$4.01M-$280.00K$0.00$2.00M$216.00K
2024-12-31$274.00K*-$4.37M*-$1.30M*$7.16M*$0.00*-$4.57M*
2024-09-30$472.00K*-$704.00K*-$727.00K*$0.00*$4.50M*-$3.95M*
2024-06-30$1.29M*-$853.00K*-$539.00K*$0.00*$4.00M*-$2.45M*
2024-03-31-$1.86M-$1.18M-$164.00K$2.70M*$2.40M-$766.00K
2023-12-31-$3.06M*-$97.00K*-$540.00K*$2.50M*$0.00*
2023-09-30$3.56M*-$3.62M*-$429.00K*$1.40M*$0.00*
2023-06-30$3.45M*-$2.35M*-$430.00K*$0.00*$0.00*
2023-03-31$1.76M-$209.00K-$730.00K$0.00$0.00$748.00K
2022-12-31$1.60M*-$56.00K*-$430.00K*$0.00*$0.00*$0.00*
2022-09-30$1.54M*-$236.00K*-$1.30M*$0.00*$0.00*
2022-06-30$3.83M*-$30.00K*-$242.00K*
2022-03-31$259.00K-$66.00K-$55.00K$138.00K
2021-12-31$3.12M*-$1.33M*-$430.00K*$0.00*$0.00*
2021-09-30-$684.00K*-$118.00K*-$243.00K*$0.00*$0.00*
2021-06-30$1.04M*$836.00K*-$2.98M*$4.52M*
2021-03-31$2.78M-$1.06M-$276.00K-$754.00K*$688.00K
2020-12-31$1.69M*-$127.00K*-$340.00K*$0.00*$0.00*-$879.00K*
2020-09-30$1.22M*-$452.00K*-$324.00K*$0.00*$0.00*-$866.00K*
2020-06-30$3.45M*-$1.61M*-$508.00K*
2020-03-31$3.39M-$195.00K-$554.00K-$1.40M*$1.24M
2019-12-31$1.76M*-$101.00K*-$416.00K*$1.00K*-$1.11M*
2019-09-30$1.91M*-$143.00K*-$587.00K*-$1.79M*
2019-06-30$1.91M*-$474.00K*-$461.00K*-$1.12M*
2019-03-31$2.46M-$272.00K-$516.00K-$1.06M*$607.00K
2018-12-31$1.84M*-$339.00K*-$592.00K*$0.00*-$1.30M*
2018-09-30$671.00K*-$395.00K*-$597.00K*-$1.33M*
2018-06-30$2.94M*-$295.00K*-$794.00K*-$1.11M*
2018-03-31$2.62M-$497.00K-$484.00K-$1.04M*$599.00K
2017-12-31$2.88M*-$43.00K*-$719.00K*-$1.28M*$937.00K*
2017-09-30$938.00K*-$283.00K*-$432.00K*-$1.41M*-$1.29M*
2017-06-30$2.39M*-$213.00K*-$668.00K*-$1.31M*$198.00K*
2017-03-31$1.65M-$114.00K-$495.00K-$1.51M*-$468.00K
2016-12-31$2.68M*$8.00K*-$585.00K*-$882.00K*$1.23M*
2016-09-30$2.29M*-$475.00K*-$324.00K*-$1.41M*$82.00K*
2016-06-30$1.68M*-$242.00K*-$620.00K*-$1.20M*-$376.00K*
2016-03-31$1.72M-$333.00K-$1.44M-$69.00K
2015-12-31$2.39M*-$399.00K*$0.00*-$641.00K*-$1.33M*$25.00K*
2015-09-30$2.29M*-$178.00K*$0.00*-$438.00K*-$1.29M*$386.00K*
2015-06-30$2.54M*-$1.16M*$0.00*-$578.00K*$871.00K*
2015-03-31$1.33M-$188.00K$0.00-$401.00K-$872.00K*-$132.00K
2014-12-31$2.36M*-$4.88M*$0.00*-$806.00K*$2.97M*-$348.00K*
2014-09-30$2.02M*-$46.00K*$0.00*-$685.00K*-$819.00K*$471.00K*
2014-06-30$988.00K*$619.00K*$0.00*-$816.00K*-$813.00K*-$13.00K*
2014-03-31$1.40M-$147.00K-$2.00K-$956.00K-$1.23M*-$952.00K
2013-12-31$1.79M*$1.44M*$0.00*-$939.00K*-$2.40M*-$58.00K*
2013-09-30$2.69M*$24.00K*$0.00*-$1.08M*-$978.00K*$610.00K*
2013-06-30$1.71M*-$3.07M*$291.00K*-$709.00K*$1.82M*$334.00K*
2013-03-31$1.88M-$119.00K-$291.00K-$790.00K-$941.00K*-$553.00K
2012-12-31$2.47M*-$2.67M*$1.00K*-$3.87M*$4.79M*$846.00K*
2012-09-30$1.64M*-$304.00K*$0.00*-$996.00K*-$503.00K*-$286.00K*
2012-06-30$1.37M*-$602.00K*-$882.00K*-$668.00K*-$786.00K*
2012-03-31$1.39M-$3.09M-$1.07M$1.97M*-$792.00K
2011-12-31$1.29M*-$4.53M*$0.00*-$1.02M*$6.19M*$1.94M*
2011-09-30$2.48M*-$1.98M*$0.00*-$1.17M*$517.00K*-$152.00K*
2011-06-30-$318.00K*$1.79M*-$860.00K*-$1.18M*-$566.00K*
2011-03-31$3.40M-$938.00K-$844.00K-$1.67M*-$54.00K
2010-12-31$2.46M*$136.00K*-$876.00K*-$1.37M*$347.00K*
2010-09-30$1.95M*-$202.00K*-$2.26M*$1.08M*$564.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45